Table 4

Patient groups	Clinical pregnancy n (%)	Ongoing pregnancy n (%)
Table 4. Day 3 ET outcomes in POSEIDON and non-POSEIDON groups.
POSEIDON I n=50 <35Y, ≥1.2ng/ml AMH	13 (28%)^a	13 (26%)^a
POSEIDON II n=40 ≥35Y, ≥1.2ng/ml AMH	7 (17%)^b	6 (15%)^b
POSEIDON III n=63 <35Y, <1.2ng/ml AMH	16 (26%)^a	15 (24%)^a
POSEIDON IV n=89 ≥35Y, <1.2ng/ml AMH	12 (13%)^b	10 (11%)^b
Non-POSEIDON <35Y, n=39	11 (28%)^a	10 (25%)^a
Non- POSEIDON ≥35Y, n=49	9 (18%)^b	7 (14%)^b
Total n=330	69 (21%)	61 (18%)

^a:b values with different superscripts within the same column differ significantly (p<0.05).